Stocks / DGX
DGX stock forecast
QUEST DIAGNOSTICS INC · Healthcare · Diagnostics & Research
The model's rating
Underperform
DGX is rated Underperform as of September 29, 2026: its medium-term return forecast is below the middle of the stocks the model scores, but above the bottom fifth.
Create a free account to compare any two stocks; the numeric score is part of Premium.
DGX is not among the 20 largest holdings published for 2026 Q4. See the portfolio
DGX against the S&P 500
| Period | DGX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -3.0% | -0.3% |
| 3 months | +8.3% | +2.5% |
| Year to date | +36.1% | +12.7% |
| 1 year | +24.4% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $233.07 |
| Market cap | 25.72 Billion |
| P/E (trailing 12 months) | 24.4 |
| P/S (trailing 12 months) | 2.2 |
| P/B (latest quarter) | 3.3 |
| Gross margin | 33.1% |
| Net profit margin | 9.2% |
| Return on equity | 14.5% |
| Beta | -0.1 |
As of July 23, 2026.
DGX and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC | 24.99 Billion | Underperform | DGX vs LH |
| MTD | METTLER TOLEDO INTERNATIONAL INC | 30.27 Billion | Greatly Underperform | MTD vs DGX |
| RVTY | REVVITY INC | 17.06 Billion | Underperform | DGX vs RVTY |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 14.08 Billion | Greatly Underperform | DGX vs CRL |
| IDXX | IDEXX LABORATORIES INC | 41.14 Billion | Greatly Underperform | |
| ILMN | ILLUMINA INC | 41.33 Billion | Outperform |
Questions
What does the Upfront Investment model say about DGX?
The model rates QUEST DIAGNOSTICS INC (DGX) "Underperform" as of September 29, 2026, which means its medium-term return forecast is below the middle of the stocks the model scores, but above the bottom fifth. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the DGX rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is DGX in the Upfront Investment model portfolio?
DGX is not among the 20 largest holdings published for 2026 Q4.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.